Moheb Nasr

2.5k total citations
30 papers, 898 citations indexed

About

Moheb Nasr is a scholar working on Cell Biology, Spectroscopy and Biomedical Engineering. According to data from OpenAlex, Moheb Nasr has authored 30 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cell Biology, 6 papers in Spectroscopy and 6 papers in Biomedical Engineering. Recurrent topics in Moheb Nasr's work include Proteoglycans and glycosaminoglycans research (7 papers), Analytical Chemistry and Chromatography (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Moheb Nasr is often cited by papers focused on Proteoglycans and glycosaminoglycans research (7 papers), Analytical Chemistry and Chromatography (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Moheb Nasr collaborates with scholars based in United States, United Kingdom and Switzerland. Moheb Nasr's co-authors include Markus Krumme, Lucinda F. Buhse, David A. Keire, Ali Al‐Hakim, Charles L. Cooney, Salvatore Mascia, Konstantin Konstantinov, Alastair J. Florence, Bernhardt L. Trout and Richard D. Braatz and has published in prestigious journals such as Nature Biotechnology, Analytical Chemistry and The Journal of Physical Chemistry.

In The Last Decade

Moheb Nasr

30 papers receiving 866 citations

Peers

Countries citing papers authored by Moheb Nasr

Since Specialization

Citations

This map shows the geographic impact of Moheb Nasr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moheb Nasr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moheb Nasr more than expected).

Fields of papers citing papers by Moheb Nasr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moheb Nasr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moheb Nasr. The network helps show where Moheb Nasr may publish in the future.

Co-authorship network of co-authors of Moheb Nasr

This figure shows the co-authorship network connecting the top 25 collaborators of Moheb Nasr. A scholar is included among the top collaborators of Moheb Nasr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moheb Nasr. Moheb Nasr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Emerging Applications and Regulatory Strategies for Advanced Medicines Manufacturing – Towards the Development of a Platform Approach 2024 ·Journal of Pharmaceutical Sciences ·Jagjit Singh Srai, (unknown), (unknown), Massimo Bresciani, Charles L. Cooney, Alastair J. Florence, (unknown), Konstantin Konstantinov, Sau L. Lee, Salvatore Mascia, Moheb Nasr, Bernhardt L. Trout	4
2	Why We Need Continuous Pharmaceutical Manufacturing and How to Make It Happen 2019 ·Journal of Pharmaceutical Sciences ·(unknown), Charles L. Cooney, Alastair J. Florence, Konstantin Konstantinov, Markus Krumme, Salvatore Mascia, Moheb Nasr, Bernhardt L. Trout	96
3	Regulatory Perspectives on Continuous Pharmaceutical Manufacturing: Moving From Theory to Practice 2017 ·Journal of Pharmaceutical Sciences ·Moheb Nasr, Markus Krumme, (unknown), Bernhardt L. Trout, (unknown), Salvatore Mascia, Charles L. Cooney, Keith D. Jensen, Alastair J. Florence, Craig A. Johnston, Konstantin Konstantinov, Sau L. Lee	103
4	The US regulatory and pharmacopeia response to the global heparin contamination crisis 2016 ·Nature Biotechnology ·(unknown), Edward K. Chess, K. B. JOHANSEN, (unknown), Elaine Gray, David A. Keire, Robert J. Linhardt, Jian Liu, Tina S. Morris, Barbara Mulloy, Moheb Nasr, Zachary Shriver, (unknown), Christian Viskov, Roger Williams, Janet Woodcock, Wesley E. Workman, Ali Al‐Hakim	86
5	Regulatory and Quality Considerations for Continuous Manufacturing May 20–21, 2014 Continuous Manufacturing Symposium 2015 ·Journal of Pharmaceutical Sciences ·(unknown), (unknown), Charles L. Cooney, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Rapti D. Madurawe, (unknown), Frank Montgomery, Moheb Nasr, (unknown), Jean‐Louis Robert, (unknown), (unknown)	121
6	Control Systems Engineering in Continuous Pharmaceutical Manufacturing May 20–21, 2014 Continuous Manufacturing Symposium 2014 ·Journal of Pharmaceutical Sciences ·Allan S. Myerson, Markus Krumme, Moheb Nasr, (unknown), Richard D. Braatz	75
7	Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns 2011 ·Analytical and Bioanalytical Chemistry ·Cynthia D. Sommers, Hongping Ye, Richard E. Kolinski, Moheb Nasr, Lucinda F. Buhse, Ali Al‐Hakim, David A. Keire	32
8	Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data 2011 ·Analytical and Bioanalytical Chemistry ·Qingda Zang, David A. Keire, Lucinda F. Buhse, Richard D. Wood, D.P. Mital, (unknown), Shankar Srinivasan, Christine Moore, Moheb Nasr, Ali Al‐Hakim, Michael L. Trehy, William J. Welsh	19
9	Characterization of currently marketed heparin products: key tests for quality assurance 2010 ·Analytical and Bioanalytical Chemistry ·David A. Keire, Hongping Ye, Michael L. Trehy, Wei Ye, Richard E. Kolinski, Benjamin J. Westenberger, Lucinda F. Buhse, Moheb Nasr, Ali Al‐Hakim	32
10	Determination of galactosamine impurities in heparin samples by multivariate regression analysis of their 1H NMR spectra 2010 ·Analytical and Bioanalytical Chemistry ·Qingda Zang, David A. Keire, Richard D. Wood, Lucinda F. Buhse, Christine Moore, Moheb Nasr, Ali Al‐Hakim, Michael L. Trehy, William J. Welsh	19
11	Combining 1H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants 2010 ·Journal of Pharmaceutical and Biomedical Analysis ·Qingda Zang, David A. Keire, Richard D. Wood, Lucinda F. Buhse, Christine Moore, Moheb Nasr, Ali Al‐Hakim, Michael L. Trehy, William J. Welsh	17
12	Characterization of Currently Marketed Heparin Products: Reversed-Phase Ion-Pairing Liquid Chromatography Mass Spectrometry of Heparin Digests 2010 ·Analytical Chemistry ·(unknown), Lucinda F. Buhse, Moheb Nasr, Ali Al‐Hakim, David A. Keire	43
13	Stability, Dose Uniformity, and Palatability of Three Counterterrorism Drugs—Human Subject and Electronic Tongue Studies 2005 ·Pharmaceutical Research ·Nakissa Sadrieh, (unknown), Lawrence X. Yu, William H. Doub, Arthur B. Straughn, Stella G. Machado, (unknown), (unknown), Terry W. Moore, John C. Reepmeyer, (unknown), (unknown), Rosemary Roberts, Donald J. Schuirmann, Moheb Nasr, Lucinda F. Buhse	41
14	Stable isotopic characterization of active pharmaceutical ingredients 2004 ·Journal of Pharmaceutical and Biomedical Analysis ·John P. Jasper, Benjamin J. Westenberger, John Spencer, Lucinda F. Buhse, Moheb Nasr	42
15	Qualification of analytical instruments for use in the pharmaceutical industry: A scientific approach 2004 ·AAPS PharmSciTech ·Surendra K. Bansal, Thomas Layloff, (unknown), (unknown), (unknown), (unknown), (unknown), Moheb Nasr, (unknown), Vinod P. Shah	28
16	The FDA regulatory methods validation program for new and abbreviated new drug applications 2000 ·Thomas Layloff, Moheb Nasr, R. W. Baldwin, (unknown), (unknown), Joseph P. Hanig, Charles Hoiberg, (unknown), (unknown), James T. MacGregor, (unknown), Erin Murphy, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Roger Williams	4
17	Algorithms for Validating Chiral Properties of Insulins 1999 ·Analytical Chemistry ·Neil Purdie, (unknown), Thomas Layloff, Moheb Nasr	2
18	Effect of Drug Load and Plate Coating on the Particle Size Distribution of a Commercial Albuterol Metered Dose Inhaler (MDI) Determined Using the Andersen and Marple-Miller Cascade Impactors 1997 ·Pharmaceutical Research ·Moheb Nasr, Danna L. Ross, (unknown)	21
19	High Performance Liquid Chromatographic Analysis of Erythromycin and Related Impurities in Pharmaceutical Formulations 1997 ·Journal of Liquid Chromatography & Related Technologies ·Moheb Nasr, (unknown)	9
20	Loading Effect on Particle Size Measurements by Inertial Sampling of Albuterol Metered Dose Inhalers 1995 ·Pharmaceutical Research ·Moheb Nasr, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact